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Background: Antimicrobial resistance (AMR) is a major public health problem. Elderly residents in long-term-
care facilities (LTCFs) are frequently prescribed antibiotics, particularly for urinary tract infections. Optimizing
appropriate antibiotic use in this vulnerable population requires close collaboration between NHS healthcare pro-
viders and LTCF providers.
Objectives: Our aim was to identify and quantify antibiotic prescribing in elderly residents in UK LTCFs. This is
part of a wider programme of work to understand opportunities for pharmacy teams in the community to sup-
port residents and carers.
Methods: This was a retrospective longitudinal cohort study. Data were extracted from a national pharmacy
chain database of prescriptions dispensed for elderly residents in UK LTCFs over 12 months (November 2016–
October 2017).
Results: Data were analysed for 341536 residents in LTCFs across the four UK nations, from which a total of
544796 antibiotic prescriptions were dispensed for 167002 residents. The proportion of residents prescribed at
least one antibiotic over the 12 month period varied by LTCF, by month and by country.
Conclusions: Whilst national data sets on antibiotic prescribing are available for hospitals and primary care, this
is the first report on antibiotic prescribing for LTCF residents across all four UK nations, and the largest reported
data set in this setting. Half of LTCF residents were prescribed at least one antibiotic over the 12 months, suggest-
ing that there is an opportunity to optimize antibiotic use in this vulnerable population to minimize the risk of
AMR and treatment failure. Pharmacy teams are well placed to support prudent antibiotic prescribing and
improved antimicrobial stewardship in this population.
Introduction
Antimicrobial resistance (AMR) is a major global public health prob-
lem which could ultimately prevent the treatment of common
bacterial infections.1 International as well as national efforts exist
to try to deal with the issues.2 The UK Government is committed to
improving the appropriate use of antibiotics in all four nations
across England, Northern Ireland, Scotland and Wales, and in
2016 set a target to reduce inappropriate prescribing by 50% by
the year 2020.3 Inappropriate use of antibiotics includes prescrib-
ing an antibiotic in the absence of evidence or clear rationale of a
bacterial infection, and continuation of the course beyond recom-
mended guidelines.4 National guidance for the management of
common infections in primary care is published by PHE,5 and more
recently by NICE.6 Research published by PHE has quantified the
level of inappropriate prescribing in primary care in England as
20%,7 suggesting that levels of prescribing should be reduced by
10% to meet the Government target. This has been integrated into
national targets in England.
There are 459000 residential places in long-term-care facilities
(LTCFs) across England,8 16000 across Northern Ireland,9 41000
across Scotland10 and 26000 across Wales.11 The majority of resi-
dents in LTCFs are elderly and have complex healthcare needs
that are exacerbated by multiple comorbidities and medication-
related issues from polypharmacy.12 Nurses and carers provide
the majority of long-term care for older people in UK LTCFs; they
help residents to live in an environment they can call home, where
quality of life matters.13 Across the UK, pharmacists (particularly
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those working in the community setting) support residents within
LTCFs by dispensing and supplying medicines, as well as providing
advice and support to carers on medicine use, storage and waste.
Providing high-quality care for LTCF residents requires close collab-
oration between healthcare providers and LTCF managers to sup-
port both residents and carers.14 Residents in these settings are
known to be prescribed higher rates of antibiotics, particularly for
urinary tract infections (UTIs),15 which are frequently associated
with antibiotic-resistant organisms that can lead to treatment fail-
ure and bloodstream infections. Issues can exist with diagnosis of
infections, as up to half of adults over the age of 65 years old and
most people with a urinary catheter will have bacteria present in
the bladder without signs of an infection.16
The 2016–17 point prevalence survey (PPS) coordinated by the
ECDC17 found that 6.2% of residents in LTCFs in Scotland were tak-
ing at least one antimicrobial, 10.1% in Wales and 10.3% in
Northern Ireland. England did not participate in this PPS, but results
from an earlier 2013 European survey found that 9.0% of residents
were taking at least one antimicrobial.18 Similarly, a 2016 PPS in
Australia reported that 9.7% of residents were prescribed antibiot-
ics, most frequently for pneumonia, UTIs and skin or soft tissue
infections.19 A 2011 retrospective longitudinal cohort study in
England (following 7481 residents over a period of 12 months)
found that annual prescriptions for antibiotics in those aged
75 years and older increased from 142/100 to 199/100 among
those living in an LTCF.15
Collecting data in LTCFs to understand healthcare needs of resi-
dents and carers can be complex and challenging as these envi-
ronments are residents’ homes, and not NHS healthcare
settings.13 The objective of this study was to identify the scale of
antibiotic prescribing in LTCFs across all four UK nations, and is part
of a programme of work to identify opportunities for community
pharmacists to support both residents and carers.
Methods
This was a retrospective longitudinal cohort study. Anonymized data were
extracted using SQL query analyser from a national pharmacy chain data-
base on NHS antibiotic prescriptions dispensed for residents in LTCFs across
the UK for 12 months from November 2016 to October 2017. Antibiotics
were defined as those listed within British National Formulary20 Chapter 5.1
(antibacterial drugs). Data fields extracted were: anonymized patient
identifier, dispensed date, drug name, code, form (e.g. capsules, tablets,
injection or suspension), strength, pack size, dosage directions and dis-
pensed quantity. Days of therapy were calculated using fields of quan-
tity dispensed and dosage instructions, and were calculable for 75.6% of
antibiotics. Although data on age were not collected, the information
extracted was based on dispensing services provided mainly to residen-
tial and nursing homes and will therefore primarily be aimed at elderly
residents. All analysis was conducted in Microsoft Excel 2013. The study
was approved by the Research Governance Board within the pharmacy
chain who confirmed that ethics approval was not required as the study
was based on an internal audit of anonymized data to help inform
service development to the LTCF resident population serviced by the
national pharmacy chain.
Results
Data were analysed for 341536 residents in LTCFs across the UK
(287912 in England, 28076 in Scotland, 16409 in Wales and 9139
in Northern Ireland). The percentage of residents receiving at least
one antibiotic prescription during the 12 month period November
2016–October 2017 was: 56.6% in Northern Ireland, 53.2% in
Scotland, 48.5% in England and 45.0% in Wales. The mean per-
centage of residents prescribed antibiotics each month by country
(Figure 1) was 21.4% in Northern Ireland, 17.4% in Scotland,
16.6% in England and 16.0% in Wales.
Half of the residents (52.1%) were dispensed one antibiotic
drug over the 12 month period, a quarter (27.5%) were dispensed
two different antibiotics, 12.9% were dispensed three and 5.1%
were dispensed four (the remaining 2.4% were dispensed between
5 and 10 different antibiotics). If a resident only had amoxicillin
over the 12 months then this would be classed as one drug, even if
they had several prescriptions for it. The distribution of the number
of antibiotic prescriptions per resident over the 12 month period is
positively skewed, with a median of 2 (IQR 1–4). Of those residents
taking antibiotics over the 12 month period, 38.4% had one anti-
biotic prescription, 21.3% had two, 12.5% had three, 7.9% had four
and 19.9% had five or more antibiotic prescriptions. In total,
10561 residents (6.3%) had10 antibiotic prescriptions during the
12 month period. Here, the definition of prescription would include
the same antibiotic being dispensed more than once over the
12 month period (e.g. a resident having three prescriptions for
amoxicillin and a further two for trimethoprim over the 12 months
would be classed as having five prescriptions).
Four antibiotics (amoxicillin, trimethoprim, nitrofurantoin and
flucloxacillin) accounted for 66.4% of all antibiotic prescribing. The
11 antibiotics shown in Figure 2 accounted for 92.8% of all anti-
biotic prescribing, of which it was possible to calculate days of ther-
apy for 77.0% of them. Figure 2 shows the days of therapy
variation for each of these antibiotics; for example, amoxicillin
accounted for 22.1% of antibiotics dispensed with a calculable
value for days of therapy, of which 73.6% were for 6–7 days and
22.0% for 4–5 days. Trimethoprim accounted for 21.8% of antibi-
otics, of which 30.0% were for 21–28 days, 29.5% for 6–7 days,
23.6% for 1–3 days and 13.4% for 4–5 days.
Discussion
Whilst the results presented herein are focused on antibiotic use,
they highlight that some residents in LTCFs take multiple courses
of antibiotics over a 12 month period, and that there is wide vari-
ability in days of therapy. Rates of antibiotic consumption are
higher than seen in previous studies,15,17–19 although these were
based on a single point in time rather than a 12 month period as
seen here. Although no information was available on the reason
for the antibiotic prescription from the data set used, some indica-
tion can be assumed for certain antibiotics (particularly where not
broad spectrum) and, therefore, comparison can be made on ap-
propriateness of prescription duration and variation against clinical
indication and national guidelines.5,6 For antibiotics used routinely
for treatment of respiratory infections, amoxicillin had a consistent
dosage length of 5 or 7 days (93.6% of prescriptions), phenoxy-
methylpenicillin for 5–10 days was 33.5% and doxycycline for
5–10 days was 62.1%. For UTI antibiotics, trimethoprim and nitro-
furantoin had wide variability, with,60% of each being for the rec-
ommended 3 or 7 days duration. For skin infections, flucloxacillin
duration of 7 days accounted for 76.1% of prescriptions and a
Thornley et al.
2 of 5
D
ow
nloaded from
 https://academ
ic.oup.com
/jac/advance-article-abstract/doi/10.1093/jac/dkz008/5304212 by guest on 14 February 2019
0%
5%
10%
15%
20%
25%
30%
Nov-16 Dec-16 Jan-17 Feb-17 Mar-17 Apr-17 May-17 Jun-17 Jul-17 Aug-17 Sep-17 Oct-17
Pe
rc
en
ta
ge
 o
f c
ar
e 
ho
m
e 
re
si
de
nt
s
Month
NI
W
E
S
Figure 1. Mean percentage of LTCF residents prescribed antibiotics by month and country. NI, Northern Ireland; S, Scotland; E, England; W, Wales.
This figure appears in colour in the online version of JAC and in black and white in the print version of JAC.
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Figure 2. Days of therapy by antibiotic. POT, period of treatment. Figure 2 is reproduced for England, Northern Ireland, Scotland and Wales in Figures
S1–S4 (available as Supplementary data at JAC Online). This figure appears in colour in the online version of JAC and in black and white in the print
version of JAC.
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further 3.1% for 14 days. Most of the penicillin prescriptions
appeared to be for prophylaxis, with 59.0% of items dispensed as
28 day courses.
Antibiotics can be given in response to unscheduled care (un-
planned health or social care) which can include prescribing out of
hours by healthcare professionals not normally involved in the
care of those residents. Pharmacists have a role in supporting the
safe and effective use of medicines in LTCFs, including promoting
self-care (through homely remedy policies), helping carers to iden-
tify and deal with early signs of deterioration and, when antibiotics
are prescribed, providing advice on whether they are appropriate
(in line with local guidelines) and to support them being used ef-
fectively.21 In 2014 the Five Year Forward View22 was published,
which aimed to promote integrated working across healthcare dis-
ciplines and sectors, in order to promote more efficient and effect-
ive care within the NHS. To support this, and enable pharmacists
and their teams to spend more time delivering clinical care to
patients across NHS settings (including LTCFs), the Pharmacy
Integration Fund was created.23 The fund is part of a national
scheme to help facilitate using pharmacists’ clinical skills further,
embedding them into practice and supporting integrated care
alongside other healthcare professionals. Given the acute nature
of many antibiotic prescriptions, pharmacists working with LTCFs
need to work alongside pharmacists within the community, pro-
viding dispensing services to these residents (although with
increasing portfolio careers these can often be the same individu-
als, or within the same teams). Community pharmacy teams dis-
pense acute prescriptions for antibiotics for residents, and can
identify potential interactions with current medications and any
known allergies. Extending the use of the summary care record by
all pharmacists to provide additional information and advice to
residents and carers can support the antibiotic being used effect-
ively as part of local guidelines (including days of therapy and asso-
ciated advice on use). Given the role of carers within LTCFs, there is
an opportunity for pharmacy teams to work more closely with
them as partners to deliver healthcare to residents, in supporting
appropriate and effective use of antibiotics, including infection pre-
vention measures such as flu vaccinations and encouraging ad-
equate hydration to prevent UTIs.21
Limitations
Although the data reported are only from one national pharmacy
chain, they are likely to be representative of the situation across
the UK owing to the large sample size and inclusion of homes that
are classed as independent (sole providers) as well as large nation-
al care organizations (multisite). The data are limited by being de-
pendent on what is captured as part of the prescription dispensing
process, and therefore miss further opportunities to explore the
data further on appropriateness compared with diagnosis and clin-
ical outcome. This could be an opportunity for exploration in future
research, alongside looking at concurrent and sequential use of
antibiotics.
Conclusions
This study provides baseline data that highlight the levels of anti-
biotic use across LTCFs in the UK, including multiple courses and
variability in duration of treatment, identifying potential areas in
which pharmacists and their teams can support both residents
and carers in the appropriate and effective use of antibiotics.
Following the recent focus on increasing the clinical role of phar-
macists within LTCFs, there is an opportunity to consider actions to
support prudent antibiotic prescribing and improved antimicrobial
stewardship across the UK, and to revisit the audit at a later date
to understand evidence of their impact.
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